International Journal of Clinical Oncology and Cancer Research

Volume 9, Issue 1, March 2024

  • Research Article

    Comparative Study of Whole Brain Radiotherapy vs Whole Brain Radiotherapy with Concurrent Temozolomide in Brain Metastases

    Md Ruhul Amin Bhuiyan*, Farhana Hussain Sadia, Ahammad Al Mamun Sweet, Md Ershadul Haque, Khandaker Md. Rezwan Bayzid, AZM Sumsuzoha, Aditi Paul Chowdhury, Md Abdul Mannan

    Issue: Volume 9, Issue 1, April 2024
    Pages: 1-10
    Received: Apr. 10, 2023
    Accepted: Jun. 10, 2023
    Published: Jan. 08, 2024
    Downloads:
    Views:
    Abstract: Background: Brain metastases are secondary tumors that develop from primary malignant tumors located outside the central nervous system. It is the most common kind of intracranial tumor in adults. Brain metastases are treated with both decisive anticancer therapy and supportive care. Objective: To compare the efficacy of whole brain radiotherapy ve... Show More
  • Research Article

    Pheochromocytoma Discovered Incidentally at the Sylvanus Olympio University Hospital in Lomé (Togo)

    Djalogue Lihanimpo*, Nemi Komi Dzidzonu, Tchamdja Toyi, Mossi Komi Edem, Djagadou Kodjo Agbéko, Balaka Abago, Djibril Mohaman Awalou

    Issue: Volume 9, Issue 1, April 2024
    Pages: 11-14
    Received: Dec. 03, 2023
    Accepted: Jan. 02, 2024
    Published: Feb. 05, 2024
    Downloads:
    Views:
    Abstract: Introduction: The diagnosis of pheocytochroma is often late compared to the appearance of symptoms, sources of morbidity and even mortality. However, pheochromocytoma can be discovered incidentally during a pathology unrelated to the tumor. Case report: We report a case revealed by acute viral hepatitis B. It’s a young subject hospitalized in the i... Show More
  • Research Article

    CDA Formulations as Persuasive Good Cancer Drugs to Save Cancer Patients

    Ming Cheng Liau*, Christine Liau Craig, Linda Liau Baker

    Issue: Volume 9, Issue 1, April 2024
    Pages: 15-24
    Received: Jan. 11, 2024
    Accepted: Jan. 22, 2024
    Published: Feb. 05, 2024
    Downloads:
    Views:
    Abstract: The objective of this study is to develop good cancer drugs to save cancer patients. Good cancer drugs are the drugs capable of inactivating abnormal methylation enzymes (MEs) to take out both cancer stem cells (CSCs) and cancer cells (CCs) by inducing these cells to undergo terminal differentiation, and to restore chemo-surveillance to save cancer... Show More